| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36e958459e9b49d2e1242c225c2187fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11b76461407954d40ae6f05ca9d60041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae6b4b5329d84a0449ca89995b51aad6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9a9ffb9f21f5fd423f00dbe48055e15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0b8c64754f51aec4bb96f6308e03e1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_995c71109762882f3cc26e74d8d61acf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-01 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70514 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
| filingDate |
2012-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e62e00c45c67a21abefc678b5788360b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa86ae62c764c7853e7c0c11f10a5629
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e00cdd7d4b13594318360a867f548c1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a0f1d86b77df334858993c0e1f22d76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e11b0390ebaba13231774cacbc8f5ed |
| publicationDate |
2012-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012183557-A1 |
| titleOfInvention |
Hiv tat-cd4 hybrid molecules and methods of use thereof |
| abstract |
Hybrid molecules comprising CD4 minimal modules or mimetics that bind to HIV Env polypeptides in combination with one or more HIV Tat polypeptides are described. Also described are complexes of these hybrid molecules with Env as well as methods of diagnosis, treatment and prevention using the polynucleotides and polypeptides. |
| priorityDate |
2005-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |